- Capital Cube•last year
ABIOMED, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 94.Our analysis is based on comparing ABIOMED, Inc. with the following peers – Thoratec Corporation, Teleflex Incorporated, Cardica, Inc., HeartWare International, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Spectranetics Corporation, Stereotaxis, Inc., AtriCure, Inc. and Kips Bay Medical, Inc. (THOR-US, (Read more...) The post ABIOMED, Inc.: Leads amongst peers with strong fundamentals appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
KIPS BAY MEDICAL, IN (KIPS)
Other OTC - Other OTC Delayed Price. Currency in USD
As of 3:56 PM EDT. Market open.
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|